Arbutus Biopharma Corporation

Arbutus Biopharma Corporationverified

ABUS

Price:

$3.51

Market Cap:

$665.12M

Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel covalently conjugated N-acetylgalactosamine (GalNAc) delivery technology; and AB-836, an oral capsid inhibitor that suppresses HBV DNA replication. The company's research and development programs include AB-161, an oral HBV RNA destabilizer to destab...[Read more]

Industry

Biotechnology

IPO Date

2007-07-26

Stock Exchange

NASDAQ

Ticker

ABUS

The Enterprise Value as of November 2024 (TTM) for Arbutus Biopharma Corporation (ABUS) is 634.72M

According to Arbutus Biopharma Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 634.72M. This represents a change of 24.05% compared to the average of 511.68M of the last 4 quarters.

Arbutus Biopharma Corporation (ABUS) Historical Enterprise Value (quarterly & annually)

How has ABUS Enterprise Value performed in the past?

The mean historical Enterprise Value of Arbutus Biopharma Corporation over the last ten years is 219.48M. The current 634.72M Enterprise Value has changed 28.82% with respect to the historical average. Over the past ten years (40 quarters), ABUS's Enterprise Value was at its highest in in the September 2024 quarter at 697.24M. The Enterprise Value was at its lowest in in the September 2019 quarter at 370.76K.

Quarterly (TTM)
Annual

Average

219.48M

Median

226.93M

Minimum

35.46M

Maximum

397.34M

Arbutus Biopharma Corporation (ABUS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Arbutus Biopharma Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 379.51%

Maximum Annual Enterprise Value = 397.34M

Minimum Annual Increase = -86.07%

Minimum Annual Enterprise Value = 35.46M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023397.34M22.98%
2022323.10M5.38%
2021306.62M39.40%
2020219.95M68.83%
2019130.28M-25.52%
2018174.91M-25.22%
2017233.91M97.26%
2016118.58M234.36%
201535.46M-86.07%
2014254.68M379.51%

Arbutus Biopharma Corporation (ABUS) Average Enterprise Value

How has ABUS Enterprise Value performed in the past?

The current Enterprise Value of Arbutus Biopharma Corporation (ABUS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

342.35M

5-year avg

275.46M

10-year avg

219.48M

Arbutus Biopharma Corporation (ABUS) Enterprise Value vs. Peers

How is ABUS’s Enterprise Value compared to its peers?

Arbutus Biopharma Corporation’s Enterprise Value is greater than VBI Vaccines Inc. (39.99M), less than ADMA Biologics, Inc. (5.03B), greater than Adaptimmune Therapeutics plc (84.53M), greater than Affimed N.V. (43.76M), greater than Corvus Pharmaceuticals, Inc. (570.78M),

CompanyEnterprise ValueMarket cap
39.99M$1.87M
5.03B$5.01B
84.53M$176.64M
43.76M$39.90M
570.78M$575.10M

Build a custom stock screener for Arbutus Biopharma Corporation (ABUS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arbutus Biopharma Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arbutus Biopharma Corporation (ABUS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arbutus Biopharma Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Arbutus Biopharma Corporation's Enterprise Value?

What is the highest Enterprise Value for Arbutus Biopharma Corporation (ABUS)?

What is the 3-year average Enterprise Value for Arbutus Biopharma Corporation (ABUS)?

What is the 5-year average Enterprise Value for Arbutus Biopharma Corporation (ABUS)?

How does the current Enterprise Value for Arbutus Biopharma Corporation (ABUS) compare to its historical average?